Measuring β-cell function relative to insulin sensitivity in youth: Does the hyperglycemic clamp suffice?

Diabetes Care

Volumn 36, Issue 6, 2013, Pages 1607-1612

  Sjaarda, Lindsey ^a   Lee, Sojung ^a   Tfayli, Hala ^b   Bacha, Fida ^c   Bertolet, Marnie ^d   Arslanian, Silva ^a  

^a CHILDREN S HOSPITAL OF PITTSBURGH   (United States)

^b AMERICAN UNIVERSITY OF BEIRUT   (Lebanon)

^c BAYLOR COLLEGE OF MEDICINE   (United States)

^d UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INSULIN;

ACCURACY; ADOLESCENT; ANALYTICAL ERROR; ARTICLE; BLAND ALTMAN ANALYSIS; BODY WEIGHT; CELL FUNCTION; CHILD; CORRELATION ANALYSIS; DISPOSITION INDEX; FEMALE; GLUCOSE CLAMP TECHNIQUE; GLUCOSE TOLERANCE; HUMAN; HYPERGLYCEMIA; HYPERINSULINEMIA; IMPAIRED GLUCOSE TOLERANCE; INSULIN SENSITIVITY; INTERMETHOD COMPARISON; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PANCREAS ISLET BETA CELL; PRESCHOOL CHILD; SCHOOL CHILD;

ADOLESCENT; CHILD; FEMALE; GLUCOSE CLAMP TECHNIQUE; HUMANS; INSULIN; INSULIN RESISTANCE; INSULIN-SECRETING CELLS; MALE;

EID: 84877707734     PISSN: 01495992     EISSN: 19355548     Source Type: Journal    
DOI: 10.2337/dc12-1508     Document Type: Article

References (40)

1. Ode KL, Frohnert BI, Nathan BM. Identification and treatment of metabolic complications in pediatric obesity. Rev Endocr Metab Disord 2009;10:167-188
2. Arslanian SA. Clamp techniques in paediatrics: what have we learned? Horm Res 2005;64(Suppl. 3):16-24 (Pubitemid 43163308)
3. Tfayli H, Lee S, Arslanian S. Declining beta-cell function relative to insulin sensitivity with increasing fasting glucose levels in the nondiabetic range in children. Diabetes Care 2010;33:2024-2030
4. Bacha F, Lee S, Gungor N, Arslanian SA. From pre-diabetes to type 2 diabetes in obese youth: pathophysiological characteristics along the spectrum of glucose dysregulation. Diabetes Care 2010;33:2225-2231
5. Kahn SE. Regulation of beta-cell function in vivo: from health to disease. Diabetes Rev 1996;4:372-389 (Pubitemid 27036129)
6. Bergman RN, Ader M, Huecking K, Van Citters G. Accurate assessment of beta-cell function: the hyperbolic correction. Diabetes 2002;51(Suppl. 1):S212-S220 (Pubitemid 34761518)
7. Ahrén B, Pacini G. Importance of quantifying insulin secretion in relation to insulin sensitivity to accurately assess beta cell function in clinical studies. Eur J Endocrinol 2004;150:97-104 (Pubitemid 38312800)
8. Bergman RN, Phillips LS, Cobelli C. Physiologic evaluation of factors controlling glucose tolerance in man: measurement of insulin sensitivity and beta-cell glucose sensitivity from the response to intravenous glucose. J Clin Invest 1981;68:1456-1467 (Pubitemid 12194400)
9. Denti P, Toffolo GM, Cobelli C. The disposition index: from individual to population approach. Am J Physiol Endocrinol Metab 2012;303:E576-E586
10. Cobelli C, Toffolo GM, Dalla Man C, et al. Assessment of beta-cell function in humans, simultaneously with insulin sensitivity and hepatic extraction, from intravenous and oral glucose tests. Am J Physiol Endocrinol Metab 2007;293:E1-E15 (Pubitemid 47105910)
11. Retnakaran R, Qi Y, Goran MI, Hamilton JK. Evaluation of proposed oral disposition index measures in relation to the actual disposition index. Diabet Med 2009;26:1198-1203
12. Sjaarda LG, Bacha F, Lee S, Tfayli H, Andreatta E, Arslanian S. Oral disposition index in obese youth from normal to prediabetes to diabetes: relationship to clamp disposition index. J Pediatr 2012;161:51-57
13. Utzschneider KM, Prigeon RL, Faulenbach MV, et al. Oral disposition index predicts the development of future diabetes above and beyond fasting and 2-h glucose levels. Diabetes Care 2009;32:335-341
14. DeFronzo RA, Tobin JD, Andres R. Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol 1979;237:E214-E223 (Pubitemid 9249478)
15. Mitrakou A, Vuorinen-Markkola H, Raptis G, et al. Simultaneous assessment of insulin secretion and insulin sensitivity using a hyperglycemia clamp. J Clin Endocrinol Metab 1992;75:379-382
16. Lee S, Guerra N, Arslanian S. Skeletal muscle lipid content and insulin sensitivity in black versus white obese adolescents: is there a race differential? J Clin Endocrinol Metab 2010;95:2426-2432
17. Tfayli H, Bacha F, Gungor N, Arslanian S. Phenotypic type 2 diabetes in obese youth: insulin sensitivity and secretion in islet cell antibody-negative versus -positive patients. Diabetes 2009;58:738-744
18. Gungor N, Bacha F, Saad R, Janosky J, Arslanian S. Youth type 2 diabetes: insulin resistance, beta-cell failure, or both? Diabetes Care 2005;28:638-644
19. George L, Bacha F, Lee S, Tfayli H, Andreatta E, Arslanian S. Surrogate estimates of insulin sensitivity in obese youth along the spectrum of glucose tolerance from normal to prediabetes to diabetes. J Clin Endocrinol Metab 2011;96:2136-2145
20. Sjaarda LA, Michaliszyn SF, Lee S, et al. HbA1c diagnostic categories and beta-cell function relative to insulin sensitivity in overweight/obese adolescents. Diabetes Care 2012;35:2559-2563
21. Burns SF, Lee S, Arslanian SA. In vivo insulin sensitivity and lipoprotein particle size and concentration in black and white children. Diabetes Care 2009;32:2087-2093
22. Bacha F, Gungor N, Lee S, Arslanian SA. In vivo insulin sensitivity and secretion in obese youth: what are the differences between normal glucose tolerance, impaired glucose tolerance, and type 2 diabetes? Diabetes Care 2009;32:100-105
23. Tfayli H, Bacha F, Gungor N, Arslanian S. Islet cell antibody-positive versus -negative phenotypic type 2 diabetes in youth: does the oral glucose tolerance test distinguish between the two? Diabetes Care 2010;33:632-638
24. Libman IM, Barinas-Mitchell E, Bartucci A, Robertson R, Arslanian S. Reproducibility of the oral glucose tolerance test in overweight children. J Clin Endocrinol Metab 2008;93:4231-4237 (Pubitemid 352789516)
25. American Diabetes Association. Standards of medical care in diabetesd 2010. Diabetes Care 2010;33(Suppl. 1):S11-S61
26. Bacha F, Gungor N, Arslanian SA. Measures of beta-cell function during the oral glucose tolerance test, liquid mixed-meal test, and hyperglycemic clamp test. J Pediatr 2008;152:618-621
27. Arslanian SA, Saad R, Lewy V, Danadian K, Janosky J. Hyperinsulinemia in africanamerican children: decreased insulin clearance and increased insulin secretion and its relationship to insulin sensitivity. Diabetes 2002;51:3014-3019
28. Retnakaran R, Shen S, Hanley AJ, Vuksan V, Hamilton JK, Zinman B. Hyperbolic relationship between insulin secretion and sensitivity on oral glucose tolerance test. Obesity (Silver Spring) 2008;16:1901-1907
29. Riggs DS, Guarnieri JA, Addelman S. Fitting straight lines when both variables are subject to error. Life Sci 1978;22:1305-1360 (Pubitemid 8339722)
30. Ader M, Ni TC, Bergman RN. Glucose effectiveness assessed under dynamic and steady state conditions. Comparability of uptake versus production components. J Clin Invest 1997;99:1187-1199 (Pubitemid 27142754)
31. Cnop M, Vidal J, Hull RL, et al. Progressive loss of beta-cell function leads to worsening glucose tolerance in firstdegree relatives of subjects with type 2 diabetes. Diabetes Care 2007;30:677-682 (Pubitemid 46354352)
32. Cali AMG, Man CD, Cobelli C, et al. Primary defects in beta-cell function further exacerbated by worsening of insulin resistancemark the development of impaired glucose tolerance in obese adolescents. Diabetes Care 2009;32:456-461
33. D'Adamo E, Caprio S. Type 2 diabetes in youth: epidemiology and pathophysiology. Diabetes Care 2011;34(Suppl. 2):S161-S165
34. Kahn SE, Prigeon RL, McCulloch DK, et al. Quanti fication of the relationship between insulin sensitivity and beta-cell function in human subjects. Evidence for a hyperbolic function. Diabetes 1993;42:1663-1672 (Pubitemid 23318125)
35. Uwaifo GI, Parikh SJ, Keil M, Elberg J, Chin J, Yanovski JA. Comparison of insulin sensitivity, clearance, and secretion estimates using euglycemic and hyperglycemic clamps in children. J Clin Endocrinol Metab 2002;87:2899-2905 (Pubitemid 34655360)
36. Best JD, Taborsky GJ Jr, Halter JB, Porte D Jr. Glucose disposal is not proportional to plasma glucose level in man. Diabetes 1981;30:847-850 (Pubitemid 11020058)
37. Bonora E, Moghetti P, Zancanaro C, et al. Estimates of in vivo insulin action in man: comparison of insulin tolerance tests with euglycemic and hyperglycemic glucose clamp studies. J Clin Endocrinol Metab 1989;68:374-378 (Pubitemid 19052880)
38. Alzaid AA, Dinneen SF, Turk DJ, Caumo A, Cobelli C, Rizza RA. Assessment of insulin action and glucose effectiveness in diabetic and nondiabetic humans. J Clin Invest 1994;94:2341-2348 (Pubitemid 24379607)
39. Cobelli C, Caumo A, Omenetto M. Minimal model S(G) overestimation and S(I) underestimation: improved accuracy by a Bayesian two-compartment model. Am J Physiol Endocrinol Metab 1999;277:E481-E488 (Pubitemid 29458208)
40. Goran MI, Bergman RN, Cruz ML, Watanabe R. Insulin resistance and associated compensatory responses in africanamerican and Hispanic children. Diabetes Care 2002;25:2184-2190 (Pubitemid 41071025)